IMNM - Immunome Inc Stock Price, Fair Value and News

$10.97-0.11 (-0.99%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

IMNM Price Action

Last 7 days

-12.8%

Last 30 days

17.6%

Last 90 days

-26.8%

Trailing 12 Months

31.2%

IMNM RSI Chart

IMNM Valuation

Market Cap

684.7M

Price/Earnings (Trailing)

-2.24

Price/Sales (Trailing)

67.6

Price/Free Cashflow

-7.4

IMNM Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

IMNM Fundamentals

IMNM Revenue

Revenue (TTM)

10.1M

Rev. Growth (Yr)

-18.37%

Rev. Growth (Qtr)

23.1%

IMNM Earnings

Earnings (TTM)

-305.3M

Earnings Growth (Yr)

-984%

Earnings Growth (Qtr)

-30.39%

IMNM Profitability

Return on Equity

-142.08%

Return on Assets

-118.86%

Free Cashflow Yield

-13.52%

IMNM Investor Care

Shares Dilution (1Y)

46.07%

Diluted EPS (TTM)

-8.1

IMNM Alerts

3 major insider buys recently.
JANUS HENDERSON GROUP PLC reported owning 5.8% of IMNM [2024-11-14]

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	12.7M	10.8M	10.1M	0
2023	4.0M	7.3M	10.7M	14.0M
2022	0	0	0	622.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Immunome Inc

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01 that targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

CEO	Dr. Purnanand Duddu Sarma Ph.D.
WEBSITE	https://immunome.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	37

Immunome Inc Frequently Asked Questions

What is the ticker symbol for Immunome Inc? What does IMNM stand for in stocks?

IMNM is the stock ticker symbol of Immunome Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Immunome Inc (IMNM)?

As of Fri Dec 20 2024, market cap of Immunome Inc is 684.71 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IMNM stock?

You can check IMNM's fair value in chart for subscribers.

Is Immunome Inc a good stock to buy?

The fair value guage provides a quick view whether IMNM is over valued or under valued. Whether Immunome Inc is cheap or expensive depends on the assumptions which impact Immunome Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IMNM.

What is Immunome Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, IMNM's PE ratio (Price to Earnings) is -2.24 and Price to Sales (PS) ratio is 67.6. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IMNM PE ratio will change depending on the future growth rate expectations of investors.